Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety and Efficacy of Tranilast in Combination With Allopurinol in Patients With Moderate to Severe Gout (TAnGO)

NCT01109121 is registered in ClinicalTrials.gov with Nuon Therapeutics, Inc. as lead sponsor.

NCT NCT01109121
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01109121 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Parallel Group Study to Evaluate the Safety and Efficacy of Tranilast in Combination With Allopurinol in Patients With Moderate to Severe Gout (TAnGO)
Lead sponsor
Nuon Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2010
Completion date
January 31, 2011
Enrollment
112 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

hyperuricemia, moderate to severe gout